Related references
Note: Only part of the references are listed.Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier
Sajedeh Eftekhari et al.
BRAIN RESEARCH (2015)
CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment
Lars Edvinsson
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
Marcelo E. Bigal et al.
CNS DRUGS (2014)
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
Tony W. Ho et al.
NEUROLOGY (2014)
Localization of CGRP Receptor Components, CGRP, and Receptor Binding Sites in Human and Rhesus Cerebellar Cortex
Sajedeh Eftekhari et al.
CEREBELLUM (2013)
Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
Sajedeh Eftekhari et al.
JOURNAL OF PAIN (2013)
Calcitonin gene-related peptide and its receptor components in the human sphenopalatine ganglion - Interaction with the sensory system
Anett Csati et al.
BRAIN RESEARCH (2012)
Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level
Sajedeh Eftekhari et al.
BMC NEUROSCIENCE (2011)
Tracing neural connections to pain pathways with relevance to primary headaches
Lars Edvinsson
CEPHALALGIA (2011)
Diencephalic and brainstem mechanisms in migraine
Simon Akerman et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries
Lars Edvinsson et al.
CEPHALALGIA (2010)
Measurement of vasoactive neuropeptides in biological materials: Problems and pitfalls from 30 years of experience and novel future approaches
Lars Edvinsson et al.
CEPHALALGIA (2010)
New drugs in migraine treatment and prophylaxis: telcagepant and topiramate
Lars Edvinsson et al.
LANCET (2010)
CGRP and its receptors provide new insights into migraine pathophysiology
Tony W. Ho et al.
NATURE REVIEWS NEUROLOGY (2010)
DIFFERENTIAL DISTRIBUTION OF CALCITONIN GENE-RELATED PEPTIDE AND ITS RECEPTOR COMPONENTS IN THE HUMAN TRIGEMINAL GANGLION
S. Eftekhari et al.
NEUROSCIENCE (2010)
CGRP-receptor antagonism in migraine treatment
Lars Edvinsson
LANCET (2008)
Inhibitory effect of BIBN4096BS, CGRP8-37, a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery
L. Edvinsson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache
L Edvinsson
CEPHALALGIA (2004)
An immunocytochemical investigation of human trigeminal nucleus caudalis:: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres
D Smith et al.
CEPHALALGIA (2002)
Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature
KR Oliver et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists
JJ Mallee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells
L Edvinsson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
5-HT1B and 5-HT1D receptors in the human trigeminal ganglion:: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase
MY Hou et al.
BRAIN RESEARCH (2001)
Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries
L Edvinsson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
H Doods et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
